These diseases include Crohn’s disease, inflammatory bowel disease, ulcerative colitis and asthma, where the response to IFN and inflammatory cytokines is excessive and leads to damage of the affected tissues by these cytokines (71–76) (Supplementary Table 2). This evidence concerns the gene IFNA1 and asthma.